Tandem Diabetes Care reports a 2Q growth of $222 million in 2024 By Investing.com
Tandem Diabetes Care, Inc. (NASDAQ:), a leading medical device company, has reported a significant second-quarter sales growth of $222 million...
Tandem
Tandem Diabetes Care, Dexcom announce t:slim X2 Insulin Pump availability in Canada
The Tandem Diabetes Care t:slim X2 Insulin Pump, which is compatible with glucose monitoring specialist Dexcom's G7 and G6 continuous...
